---

Export Control (Amendment) (No. 3) Order 2010

My Lords, I thank the noble Lord, Lord Young, and my noble friend Lord Razzall, for their questions. I can answer the question posed by the noble Lord, Lord Young, fast and easily. Both versions of the drug’s name are in common use. But, with his O-level chemistry background, it is right that the noble Lord should check and I am delighted that he is able to support the amendment. My noble friend Lord Razzall asked where else the drug can be obtained. It is manufactured in Austria and Italy. We have no information about suppliers outside the European Union. I am afraid that we will have to write to my noble friend as regards where the drug has been used for execution. We do not have that information at the moment. With my noble friend’s past interest—I understand my noble friend said that he has campaigned in the United States against the death penalty—obviously that information will be of interest to him. My noble friend also asked what volume has been imported. We have no figures on imports to the United States of America. It cannot lawfully be imported to the US for medical purposes, so the volumes must be very low if it is used only for this purpose. I hope that these are helpful answers. If there are no other questions, I conclude by reiterating that, on the basis of the facts outlined in the opening statement, I commend the order to the Committee. I should also like to emphasise that the operational effect of the order will be kept under review in the light of factual developments. Motion agreed.